HealthEquity, Inc. (NASDAQ:HQY) Holdings Raised by CIBC Asset Management Inc

CIBC Asset Management Inc boosted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 5.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,640 shares of the company’s stock after buying an additional 139 shares during the period. CIBC Asset Management Inc’s holdings in HealthEquity were worth $253,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. UMB Bank n.a. lifted its stake in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares during the period. Quarry LP raised its holdings in HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after purchasing an additional 1,089 shares in the last quarter. 1620 Investment Advisors Inc. acquired a new stake in HealthEquity in the third quarter worth approximately $112,000. GAMMA Investing LLC boosted its stake in HealthEquity by 32.9% during the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock valued at $120,000 after purchasing an additional 309 shares in the last quarter. Finally, Covestor Ltd grew its holdings in HealthEquity by 27.4% during the third quarter. Covestor Ltd now owns 1,524 shares of the company’s stock worth $125,000 after acquiring an additional 328 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on HQY. Royal Bank of Canada boosted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. The Goldman Sachs Group began coverage on HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Finally, Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $111.23.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,000 shares of company stock worth $3,895,788. Insiders own 2.20% of the company’s stock.

HealthEquity Stock Up 0.8 %

HQY stock opened at $109.43 on Tuesday. The stock has a market capitalization of $9.48 billion, a price-to-earnings ratio of 100.39, a price-to-earnings-growth ratio of 1.60 and a beta of 0.55. The company has a 50-day moving average of $103.98 and a two-hundred day moving average of $92.64. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the company posted $0.40 EPS. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.